July 04, 2025 05:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘We will cross that bridge when we come to it’: Jaishankar’s response on US bill proposing 500% tariffs | 'We slapped because of his attitude': MNS worker justifies assault on shopkeeper for not speaking Marathi | 'Marathi will have to be spoken in Maharashtra': State minister after MNS workers' assault on shopkeeper | PM Modi conferred with 'The Officer of the Order of the Star of Ghana' | Three Indian nationals abducted in Al-Qaeda-linked group's attack in Mali, MEA expresses 'deep concern' | Pune woman raped by man posing as delivery boy, police probe on | Kolkata gangrape case: West Bengal Bar Council expels prime accused Monojit Mishra | Contempt case: Court sentences former Bangladesh PM Sheikh Hasina to six months in prison | India has every right to defend its people against terrorism: Jaishankar at Quad Meet | Dalai Lama's institution will continue, Trust will recognise his successor
US FDA
Wallpaper Cave

US FDA adds warning on Johnson & Johnson COVID-19 vaccine related to rare neurological disorder

| @indiablooms | Jul 13, 2021, at 02:18 pm

Washington/UNI/Xinhua: The US Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the vaccine has been linked to a serious but rare side effect called Guillain-Barre syndrome.

Guillain Barre syndrome is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, the FDA said on Monday.

The syndrome has occurred in some people who have received the Johnson & Johnson vaccine. In most of these people, symptoms began within 42 days following injections of the vaccine, said the FDA in a letter.

The chance of having this occur is very low, the agency said.

About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the United States, The Washington Post quoted the U.S. Centers for Disease Control and Prevention (CDC) as saying in a statement.

Of these reports, 95 were serious and required hospitalization, and one was dead.

The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older, according to the CDC.

Johnson & Johnson said Monday it has been in discussions with the FDA and other regulators about rare cases of Guillain-Barre syndrome.

The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree, the company said in a statement.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu